Skip to main content

InvestmentPitch Media Video Discusses Reliq Health’s Signing of 5 New Contracts with 3 Primary Care Practices and 2 Home Health Agencies in the US.

Written by Customer Service on . Posted in Public Companies.

VANCOUVER, British Columbia, March 17, 2022 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT) (OTCPink:RQHTF) (FSE:MHN2), a rapidly growing global telemedicine company developing innovative Virtual Care solutions for the multibillion-dollar Healthcare market, has signed five new contracts with three primary care practices and two home health agencies in the US. The company is also expanding its mental health care capabilities beyond Behavioural Health Integration (BHI) to also support Collaborative Care Management (CoCM).

A Media Snippet accompanying this announcement is available by clicking on the image or link below:

InvestmentPitch Media Video Discusses Reliq Health’s Signing of 5 New Contracts with 3 Primary Care Practices and 2 Home Health Agencies in the US

For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company. The video is available for viewing on “InvestmentPitch.com” and on “YouTube”. If these links are not enabled, please visit www.InvestmentPitch.com and enter “Reliq” in the search box.

Dr. Lisa Crossley, CEO, stated: “We are pleased to be adding these five new clients. We are also excited to be expanding our support for mental health care by adding Collaborative Care Management (CoCM) to our platform. Our CoCM module allows primary care physicians and specialists to proactively care for patients with behavioural, mental health or psychiatric conditions including addiction. CoCM is an additional level of care that can be offered to patients who aren’t responding to Behavioural Health Integration services alone. The Centers for Medicare and Medicaid Services (CMS) reimburse clinicians an average of $230 per patient per month for CoCM services, in addition to any payments the provider is receiving from CMS for other virtual care services provided to the patient including Remote Patient Monitoring (RPM) and Chronic Care Management (CCM). CoCM therefore provides a new revenue stream for clinicians while improving care for patients with the most challenging mental health and addiction issues.”

According to the American Psychiatric Association, under Collaborative Care Management, primary care and behavioral health providers collaborate using shared care plans to deliver both physical and mental health care, effectively reducing duplicate assessments. This effective and efficient integration of services has proven to be successful in terms of controlling costs, improving access, improving clinical outcomes, reducing the stigma related to mental health, and increasing patient satisfaction.

These new providers will add more than 2,000 new patients to the company’s iUGO Care platform, with onboarding expected to begin next month. The contracts include a one-time payment of $400,000 for medical monitoring device hardware and are expected to generate an average recurring revenue of over US$70 per patient per month. When the 2,000 patients are fully onboarded and generating revenues of US$70 per patient per month, the company anticipates generating revenue of more than CDN$180,000 per month.

Based in Hamilton, Ontario, with offices in Florida and Texas, Reliq specializes in developing innovative Virtual Care solutions for the multi-billion dollar healthcare market. The company’s powerful iUGO Care technology platform is a comprehensive SaaS solution that allows complex patients to receive high-quality care at home, improving health outcomes, enhancing the quality of life for patients and families, and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and emergency room visits.

The shares are trading at $0.78. For more information, please visit the company’s website, www.ReliqHealth.com or email IR@ReliqHealth.com. Investor Relations in the United States is handled by Ben Shamsian of Lytham Partners, who can be reached at 649-829-9701 or by email at shamsian@LythamPartners.com.

Disclaimer

The information in this Investmentpitch Media Ltd video is for the viewers information only. Reliq Health Technologies has paid a fee not exceeding $2,000 in cash to have its current news release produced in video format. The corporate information is based on information that is publicly available. Any information provided by Investmentpitch Media Ltd., through its media services is not to be construed as a recommendation or suggestion or offer to buy or sell securities but is provided solely as an informational media service. Investmentpitch Media Ltd makes no warranties or undertakings as to the accuracy or completeness of this information. All due diligence should be done by the viewer or their financial advisor. Investing in securities is speculative and carries risk.

About InvestmentPitch Media

InvestmentPitch Media leverages the power of video, which together with its extensive distribution, positions a company’s story ahead of the 1,000’s of companies seeking awareness and funding from the financial community. The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors.

CONTACT:
InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.